相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Kinetics of B, T, NK lymphocytes and isoagglutinin titers in ABO incompatible living donor liver transplantation using rituximab and basiliximab
Seung Duk Lee et al.
TRANSPLANT IMMUNOLOGY (2015)
Impact of Rituximab Desensitization on Blood-Type-Incompatible Adult Living Donor Liver Transplantation: A Japanese Multicenter Study
H. Egawa et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure
Tian Shen et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2014)
Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era
Gi-Won Song et al.
JOURNAL OF HEPATOLOGY (2014)
Application of Complement Component 4d Immunohistochemistry to ABO-Compatible and ABO-Incompatible Liver Transplantation
Adeeb Salah et al.
LIVER TRANSPLANTATION (2014)
SECTION 15. A DESENSITIZING PROTOCOL WITHOUT LOCAL GRAFT INFUSION THERAPY AND SPLENECTOMY IS A SAFE AND EFFECTIVE METHOD IN ABO-INCOMPATIBLE ADULT LDLT
Gi-Won Song et al.
TRANSPLANTATION (2014)
Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease
Florent Puisset et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor
Jong Man Kim et al.
JOURNAL OF HEPATOLOGY (2013)
Emergency ABO-incompatible liver transplant secondary to fulminant hepatic failure: Outcome, role of TPE and review of the literature
Robert W. Maitta et al.
JOURNAL OF CLINICAL APHERESIS (2012)
Splenectomy Does Not Offer Immunological Benefits in ABO-Incompatible Liver Transplantation With a Preoperative Rituximab
Vikram Raut et al.
TRANSPLANTATION (2012)
Rescue Splenectomy in a Case of Humoral Rejection in ABO-Incompatible Simultaneous Liver-Kidney Transplantation
Ivo Tzvetanov et al.
TRANSPLANTATION (2012)
The Use of Bortezomib as a Rescue Treatment for Acute Antibody-Mediated Rejection: Report of Three Cases and Review of Literature
I. Tzvetanov et al.
TRANSPLANTATION PROCEEDINGS (2012)
Recipient Outcomes after ABO-Incompatible Liver Transplantation: A Systematic Review and Meta-Analysis
Jian Wu et al.
PLOS ONE (2011)
Management of ABO-Incompatible Living-Donor Liver Transplantation: Past and Present Trends
Vikram Raut et al.
SURGERY TODAY (2011)
Kinetics of Anti-Blood Type Isoagglutinin Titers and B Lymphocytes in ABO-Incompatible Living Donor Liver Transplantation With Rituximab and Plasma Exchange
Hideaki Uchiyama et al.
TRANSPLANTATION (2011)
Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura
V. McDonald et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
The Role of Proteasome Inhibition With Bortezomib in the Treatment of Antibody-Mediated Rejection After Kidney-Only or Kidney-Combined Organ Transplantation
Stuart M. Flechner et al.
TRANSPLANTATION (2010)
Proteasome Inhibition Causes Apoptosis of Normal Human Plasma Cells Preventing Alloantibody Production
D. K. Perry et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Impact of low-dose rituximab on splenic B cells in ABO-incompatible renal transplant recipients
Daisuke Toki et al.
TRANSPLANT INTERNATIONAL (2009)
Rituximab, IVIG, and Plasma Exchange Without Graft Local Infusion Treatment: A New Protocol in ABO Incompatible Living Donor Liver Transplantation
Toru Ikegami et al.
TRANSPLANTATION (2009)
Ischemic Cholangiopathy
Pierre Deltenre et al.
SEMINARS IN LIVER DISEASE (2008)
Effects and Problems of Adult ABO-Incompatible Living Donor Liver Transplantation Using Protocol of Plasma Exchange, Intra-arterial Infusion Therapy, and Anti-CD20 Monoclonal Antibody Without Splenectomy: Case Reports of Initial Experiences and Results in Korea
B. -W. Kim et al.
TRANSPLANTATION PROCEEDINGS (2008)
Current status of liver transplantation across ABO blood-type barrier
Hiroto Egawa et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY (2008)
Present status of ABO-incompatible living donor liver transplantation in japan
Hiroto Egawa et al.
HEPATOLOGY (2008)
C4d immunopositivity is uncommon in ABO-compatible liver allografts, but correlates partially with lymphocytotoxic antibody status
C. O. C. Bellamy et al.
HISTOPATHOLOGY (2007)
The effect of desensitization protocols on human splenic B-cell populations in vivo
E. J. Ramos et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation
Hiroto Egawa et al.
LIVER TRANSPLANTATION (2007)
Pharmacodynamics of rituximab in kidney allotransplantation
H. Genberg et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Lessons learned from 1,000 living donor liver transplantations in a single center: How to make living donations safe
Shin Hwang et al.
LIVER TRANSPLANTATION (2006)
Rituximab can be combined with daily plasma exchange to achieve effective B-cell depletion and clinical improvement in acute autoimmune TTP
K Darabi et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
ABO-incompatible deceased donor liver transplantation with the use of antigen-specific immunoadsorption and anti-CD20 monoclonal antibody
KM Boberg et al.
CLINICAL TRANSPLANTATION (2006)
Adult ABO-incompatible liver transplantation, using A2 and B donors
U Skogsberg et al.
XENOTRANSPLANTATION (2006)
C4d in acute rejection after liver transplantation - A valuable tool in differential diagnosis to hepatitis C recurrence
M Schmeding et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Acute humoral rejection and C4d immunostaining in ABO blood-type incompatible liver transplantation
H Haga et al.
LIVER TRANSPLANTATION (2006)
Impact of recipient age in outcome of ABO-incompatible living-donor liver transplantation
H Egawa et al.
TRANSPLANTATION (2004)
Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation
H Haga et al.
LIVER TRANSPLANTATION (2004)